HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hamid Reza Rezvani Selected Research

Urban Schosser Spohn syndrome

1/2020Hereditary Mucoepithelial Dysplasia Results from Heterozygous Variants at p.Arg557 Mutational Hotspot in SREBF1, Encoding a Transcription Factor Involved in Cholesterol Homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hamid Reza Rezvani Research Topics

Disease

12Neoplasms (Cancer)
05/2022 - 01/2010
7Carcinogenesis
01/2022 - 01/2014
5Skin Neoplasms (Skin Cancer)
10/2019 - 01/2011
4Xeroderma Pigmentosum (Kaposi's Disease)
01/2022 - 06/2011
3Hypoxia (Hypoxemia)
11/2013 - 06/2007
2Adenocarcinoma of Lung
01/2022 - 11/2020
2Lung Neoplasms (Lung Cancer)
01/2022 - 11/2020
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2021 - 10/2019
2Carcinoma (Carcinomatosis)
01/2021 - 08/2017
2Genomic Instability
06/2011 - 01/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2011 - 01/2011
1Hemangioma (Angioma)
01/2021
1Urban Schosser Spohn syndrome
01/2020
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Dehydration (Water Stress)
01/2018
1Skin Diseases (Skin Disease)
01/2018
1Melanoma (Melanoma, Malignant)
08/2017
1Insulin Resistance
09/2016
1Type 2 Diabetes Mellitus (MODY)
09/2016
1Atrophy
12/2011
1Inflammation (Inflammations)
12/2011

Drug/Important Bio-Agent (IBA)

5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2011
4EnzymesIBA
05/2022 - 01/2018
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2016
3Oxygen (Dioxygen)IBA
01/2018 - 06/2007
2Propranolol (Inderal)FDA LinkGeneric
05/2022 - 01/2021
2AntioxidantsIBA
01/2022 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2011
2A-Form DNA (A-DNA)IBA
01/2022 - 10/2019
2NADPH Oxidases (NAD(P)H oxidase)IBA
03/2021 - 01/2018
2Pharmaceutical PreparationsIBA
01/2021 - 05/2011
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 01/2018
2Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2007
2p38 Mitogen-Activated Protein KinasesIBA
01/2017 - 01/2014
1CatecholaminesIBA
05/2022
1NitrosaminesIBA
01/2022
1Superoxide DismutaseIBA
01/2022
1KetonesIBA
01/2022
1Annexin A1IBA
01/2022
1NicotineFDA Link
01/2022
1Mitochondrial Trifunctional ProteinIBA
01/2021
1Trimetazidine (Vastarel)IBA
01/2021
1Aquaporins (Water Channels)IBA
01/2021
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2021
1Superoxides (Superoxide)IBA
11/2020
15- (4- methoxyphenyl)- 3H- 1,2- dithiole- 3- thioneIBA
11/2020
1ProteomeIBA
11/2020
1CholesterolIBA
01/2020
1Hemeproteins (Heme Protein)IBA
10/2019
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2019
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2019
1Hypochlorous Acid (Hypochlorite)IBA
10/2019
1Peroxidase (Myeloperoxidase)IBA
10/2019
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2019
1Cytostatic AgentsIBA
01/2018
1Tricarboxylic AcidsIBA
01/2018
1MutagensIBA
01/2018
1Local AnestheticsIBA
01/2018
1Levobupivacaine (Chirocaine)FDA Link
01/2018
1Dihydroorotate DehydrogenaseIBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1NADP (NADPH)IBA
01/2017
1Plant ExtractsIBA
09/2016
1Blood Glucose (Blood Sugar)IBA
09/2016
1LipidsIBA
09/2016
1SB 203580IBA
01/2014
1IntegrinsIBA
12/2011
1Caspase 3 (Caspase-3)IBA
05/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2011
1Sirtuin 1IBA
05/2011
1TOR Serine-Threonine KinasesIBA
05/2011
1ResveratrolIBA
05/2011
1Sirolimus (Rapamycin)FDA Link
05/2011
1Mitochondrial DNA (mtDNA)IBA
01/2011
1DNA Repair EnzymesIBA
01/2010
1Messenger RNA (mRNA)IBA
01/2010

Therapy/Procedure

5Therapeutics
01/2022 - 01/2010
1Drug Therapy (Chemotherapy)
01/2022
1Investigational Therapies (Experimental Therapy)
08/2017
1Aftercare (After-Treatment)
09/2016
1Glycemic Control
09/2016
1Subcutaneous Injections
01/2011